Amyotrophic lateral sclerosis.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Internal medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/internalmedicine.34.824PMID 8580551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motor Neuron Disease

  2011cited by this paper
• Occupational exposures to metals as risk factors for Parkinson's disease

  1997cited by this paper
• [Shy-Drager syndrome and multiple system atrophy].

  1997cited by this paper
• Activation of protein kinase C by intracellular free calcium in the motoneuron cell line NSC-19.

  1997cited by this paper
• Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

  1997cited by this paper
• Lou Gehrig and amyotrophic lateral sclerosis. Is vitamin E to be revisited?

  1997cited by this paper
• Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy

  1997cited by this paper
• Prognosis in Familial Amyotrophic Lateral Sclerosis

  1997cited by this paper
• Magnetic resonance imaging at the demyelinative foci in chronic inflammatory demyelinating polyneuropathy

  1997cited by this paper
• The characteristic electrodiagnostic features of Kennedy's disease

  1997cited by this paper
• Abnormalities of cortical inhibitory neurons in amyotrophic lateral sclerosis

  1997cited by this paper
• Abnormal dephosphorylation effect on NMDA receptor regulation in ALS spinal cord.

  1997cited by this paper
• Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy

  1997cited by this paper
• Disorders of the Anterior Horn Cell

  1997cited by this paper
• Neurofilaments and motor neuron disease.

  1997cited by this paper
• Long term follow up of multifocal motor neuropathy with conduction block under treatment.

  1997cited by this paper
• Brain and spinal cord MRI in motor neuron disease.

  1997cited by this paper
• Motor neuron syndromes in cancer patients

  1997cited by this paper
• Towards a neurophysiological marker of amyotrophic lateral sclerosis as revealed by changes in cortical excitability.

  1997cited by this paper
• Evidence That Spinal Interneurons Undergo Programmed Cell Death Postnatally in the Rat

  1997cited by this paper
• Aluminum in motor neuron disease spinal cord

  1997cited by this paper
• Regional HmPAO SPECT and CT Measurements in the Diagnosis of Alzheimer's Disease

  1997cited by this paper
• Proteolytic activity in amyotrophic lateral sclerosis IgG preparations

  1996cited by this paper
• Motor neuron disease in the Padua district of Italy: an epidemiological study.

  1996cited by this paper
• Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study.

  1996cited by this paper
• Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations

  1996cited by this paper
• Incidence of amyotrophic lateral sclerosis in three counties in western Washington state

  1996cited by this paper
• Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophc lateral sclerosis

  1996cited by this paper
• Transforming growth factor‐beta 3, glial cell line‐derived neurotrophic factor, and fibroblast growth factor‐2, act in different manners to promote motoneuron survival in vitro

  1996cited by this paper
• Reduced corticomotoneuronal excitatory postsynaptic potentials (EPSPs) with normal Ia afferent EPSPs in amyotrophic lateral sclerosis

  1996cited by this paper
• SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis.

  1996cited by this paper
• The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

  1996cited by this paper
• Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients.

  1996cited by this paper
• Superoxide dismutase and familial amyotrophic lateral sclerosis: New insights into mechanisms and treatments

  1996cited by this paper
• Motor neuron growth factors

  1996cited by this paper
• Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium content.

  1996cited by this paper
• Bcl-2 Sensitivity Differentiates Two Pathways for Motoneuronal Death in the wobbler Mutant Mouse

  1996cited by this paper
• Recombinant human insulin-like growth factor-I in ALS

  1996cited by this paper
• Double cortical stimulation in amyotrophic lateral sclerosis.

  1996cited by this paper
• Management of ALS

  1996cited by this paper
• Identification of brain metabolites by magnetic resonance spectroscopy in MND/ALS.

  1996cited by this paper
• Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register.

  1996cited by this paper
• Motor neuron disease, lymphoproliferative disease, and bone marrow biopsy

  1996cited by this paper
• Frontotemporal dementia: a clinicopathological review of four postmortem studies.

  1996cited by this paper
• Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.

  1996cited by this paper
• The prevalence of lumbar paraspinal spontaneous activity in asymptomatic subjects

  1996cited by this paper
• Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients.

  1996cited by this paper
• Multifocal motor neuropathy with conduction block and Campylobacter jejuni

  1996cited by this paper
• Cell death mechanisms in ALS

  1996cited by this paper
• A controlled trial of amino acid therapy in amyotrophic lateral sclerosis

  1996cited by this paper
• Clinical trials of riluzole in patients with ALS

  1996cited by this paper
• Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum

  1996cited by this paper
• Amyotrophic lateral sclerosis and antibodies to voltage‐gated calcium channels—new doubts

  1996cited by this paper
• Transgenic animals

  1996cited by this paper
• Selective neuronal vulnerability in motor neurone diseases with reference to sparing of Onuf's nucleus.

  1996cited by this paper
• Comparative study of chronic aluminum-induced neurofilamentous aggregates with intracytoplasmic inclusions of amyotrophic lateral sclerosis

  1996cited by this paper
• A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis

  1996cited by this paper
• Molecular genetic basis of familial ALS

  1996cited by this paper
• Management of ALS

  1996cited by this paper
• An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984.

  1996cited by this paper
• [Familial amyotrophic lateral sclerosis].

  1996cited by this paper
• Glutamate Antagonists in Amyotrophic Lateral Sclerosis

  1996cited by this paper
• Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease

  1996cited by this paper
• Advances in SMA research: review of gene deletions.

  1996cited by this paper
• Clinical epidemiology of amyotrophic lateral sclerosis.

  1996cited by this paper
• Motor unit estimates obtained using the new “MUESA” method

  1996cited by this paper
• A clinical trial of verapamil in amyotrophic lateral sclerosis

  1996cited by this paper
• Issues in clinical trial design I

  1996cited by this paper
• Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF

  1995cited by this paper
• Motor unit estimation: Anxieties and achievements

  1995cited by this paper
• Neutron activation analysis of trace elements in motor neuron disease spinal cord.

  1995cited by this paper
• Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice

  1995cited by this paper
• Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

  1995cited by this paper
• Amyotrophic lateral sclerosis with paraproteins and autoantibodies.

  1995cited by this paper
• Sources of error in the spike‐triggered averaging method of motor unit number estimation (MUNE)

  1995cited by this paper
• Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis.

  1995influential reference
• A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death.

  1995cited by this paper
• Amyotrophic lateral sclerosis is a multifactorial disease

  1995influential reference
• Motor neuron disease. Studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation.

  1995cited by this paper
• Neurodegenerative 'overlap' syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease.

  1995cited by this paper
• Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells.

  1995cited by this paper
• The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study.

  1995cited by this paper
• Motor neuron-astrocyte interactions and levels of Cu,Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis.

  1995cited by this paper
• Epidemiology of ALS.

  1995cited by this paper
• Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis.

  1995cited by this paper
• Potassium currents in motoneurones.

  1995cited by this paper
• The Mouse Mutation Muscle Deficient (mdf) is Characterized by a Progressive Motoneuron Disease

  1995cited by this paper
• Nocturnal assisted ventilation using bilevel positive airway pressure: the effect of expiratory positive airway pressure.

  1995cited by this paper
• Motor conduction parameters in neuropathies associated with anti‐mag antibodies and other types of demyelinating and axonal neuropathies

  1995cited by this paper
• Neural apoptosis

  1995cited by this paper
• Number and relative size of thenar motor units estimated by an adapted multiple point stimulation method

  1995cited by this paper
• Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis.

  1995cited by this paper
• The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy.

  1995cited by this paper
• Motor neuron disease: a primary disorder of corticomotoneurons?

  1995cited by this paper
• In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons

  1995cited by this paper
• CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients.

  1995cited by this paper
• Effect of branched-chain amino acids on glutamate metabolism in amyotrophic lateral sclerosis.

  1995cited by this paper
• Multifocal motor neuropathy with conduction block: a study of 24 patients.

  1995cited by this paper
• Prognosis of amyotrophic lateral sclerosis and the effect of referral selection.

  1995cited by this paper
• Issues in amyotrophic lateral sclerosis clinical trial design.

  1995cited by this paper

• Rdh54/Tid1 inhibits Rad51-Rad54-mediated D-loop formation and limits D-loop length

  2020cites this paper
• TDP-43 modification in the hSOD1G93A amyotrophic lateral sclerosis mouse model

  2015cites this paper
• Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.

  2015cites this paper
• Changes in the clinical features of amyotrophic lateral sclerosis in rural Japan.

  2013cites this paper
• Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part II, results and discussion

  2013cites this paper
• Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases.

  2008cites this paper
• Type-2 alkenes mediate synaptotoxicity in neurodegenerative diseases.

  2008cites this paper
• Reduction of Lower Motor Neuron Degeneration inwobbler Mice byN-Acetyl-l-Cysteine

  1996cites this paper